Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Methodology Study

In brief

This study will assess the feasibility of conducting sleep studies in a clinical research unit environment. In addition, the sensitivity of polysomnography and mobile actigraphy technologies will be compared for evaluating sleep stages and sleep architecture.

Key facts

Study ID

NCT00716521

Run by

Pfizer

People needed

11

Starts

2008-07-01

Expected to finish

2008-10-01

Last updated by the study team

2009-04-24

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18-55
• BMI 18-30 kg/m2
• body weight > 50 kg

You may not qualify if…

• no history of sleep disorder
• no concurrent medications
• no alcohol use
• no medical issues
• no smoking

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.